Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diseasome and comorbidities complexities of SARS-CoV-2 infection with common malignant diseases

4 Jan 2021

Abstract excerpt

With the increasing number of immunoinflammatory complexities, cancer patients have a higher risk of serious disease outcomes and mortality with SARS-CoV-2 infection which is still not clear. In this study, we aimed to identify infectome, diseasome and comorbidities between COVID-19 and cancer via comprehensive bioinformatics analysis to identify the synergistic severity of the cancer patient for SARS-CoV-2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to COVID-19 Clinical Research Studies
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33539530
DOI: 10.1093/bib/bbab003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diseasome and comorbidities complexities of SARS-CoV-2 infection with common malignant diseasesPMID 33539530Read ↗

Identification of key molecules in COVID-19 patients significantly correlated with clinical outcomes by analyzing transcriptomic dataSemantic proximity Read ↗

Molecular signatures in the progression of COVID-19 severitySemantic proximity Read ↗

How does SARS‐CoV‐2 infection impact on immunity, procession and treatment of pan cancersSemantic proximity Read ↗

A Meta-analysis of Comorbidities in COVID-19: Which Diseases increase the Susceptibility of SARS-CoV-2 Infection?Semantic proximity Read ↗

New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge?Semantic proximity Read ↗

Cancer related-genes enriched in peripheral blood mononuclear cells (PBMCs) of COVID-19 patients. a bioinformatics studySemantic proximity Read ↗

Secondary analysis of transcriptomes of SARS-CoV-2 infection models to characterize COVID-19Semantic proximity Read ↗

In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposingSemantic proximity Read ↗

An investigation into the molecular basis of cancer comorbidities in coronavirus infection.Semantic proximity Read ↗

Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.Semantic proximity Read ↗

An Integrative Analysis Identifying Transcriptional Features and key Genes Involved in COVID-19Semantic proximity Read ↗

Identification of key genes related to immune cells in patients with COVID-19 via Integrated Bioinformatics-Based AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.